The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 09, 2010

Filed:

May. 24, 2004
Applicants:

Timo Heinrich, Groβ-Umstadt, DE;

Henning Böttcher, Darmstadt, DE;

Kai Schiemann, Seeheim-Jugenheim, DE;

Günter Hölzemann, Seeheim-Jugenheim, DE;

Christoph Van Amsterdam, Darmstadt, DE;

Gerd Bartoszyk, Weiterstadt, DE;

Joachim Leibrock, Pfungstadt, DE;

Christoph Seyfried, Seeheim-Jugenheim, DE;

Inventors:

Timo Heinrich, Groβ-Umstadt, DE;

Henning Böttcher, Darmstadt, DE;

Kai Schiemann, Seeheim-Jugenheim, DE;

Günter Hölzemann, Seeheim-Jugenheim, DE;

Christoph van Amsterdam, Darmstadt, DE;

Gerd Bartoszyk, Weiterstadt, DE;

Joachim Leibrock, Pfungstadt, DE;

Christoph Seyfried, Seeheim-Jugenheim, DE;

Assignee:

Merck Patent GmbH, Darmstadt, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); A61K 31/445 (2006.01); C07D 295/00 (2006.01); C07D 241/04 (2006.01); C07D 211/00 (2006.01); A01N 43/40 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of the formula (I), the use thereof for the preparation of a medicament for the treatment of diseases associated with the serotonin receptor and/or serotonin reuptake, in particular for the preparation of a medicament as anxiolytic, antidepressant, neuroleptic and/or antihypertonic and/or for positively influencing obsessive-compulsive disorder (OCD), sleeping disorders, tardive dyskinesia, learning disorders, age-dependent memory disorders, eating disorders, such as bulimia, and/or sexual dysfunctions. The compounds bind to the 5-HTreceptor.


Find Patent Forward Citations

Loading…